Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The world’s first vertical nanobeam to enable cancer care to be individualised for the patient

12.06.2006
The University of Surrey Ion Beam Centre (IBC) in collaboration with the Gray Cancer Institute is working on a £1.2M project which is underpinned by a prestigious grant of £800k from the Wolfson Foundation. The funding will be used to build the world’s first vertical scanning focussed nanobeam which will be used to analyse how radiation affects living cells. Radiation therapy is second only to surgery as a cure for cancer in the UK and so this research has a large potential impact on patient survival and quality of life. The new beam line will also be used to look at the processes which may lead to cancer and the risks associated with low level exposure to radiation (e.g. in structures built on or out of granite).

The new nanobeam at the IBC will be able to provide data about the radiation sensitivity of tumours. Some tumours are known to be normally radiation resistant, but display hyper-sensitivity to very low doses. This means that a very small dose of radiation can have a much larger than expected effect in terms of destroying the tumour. To help clinicians test these theories, data from the IBC will be used to the construct virtual tumours. These virtual tumours can then be used to test the efficacy of different treatment strategies.

The Ion Beam Centre already houses one of the World’s largest and most advanced facilities. In the new nanobeam, the ions will be shot into the target at about one tenth the speed of light (70,000,000 mph). In addition to helping understand the way in which radiation affects living cells, these ions can also be used to map the elemental structure of the sample in three dimensions. This is done by analysing the radiation they give off as they pass through the sample and the way in which some of them bounce back while others pass through. By carrying out all these types of analyses simultaneously a three dimensional elemental picture of the sample is constructed. Until now the IBC has been unable to analyse liquids. This is because of gravity which means that liquid samples have to be held perfectly horizontal while the analysis takes place. With a vertical beam it is therefore possible to directly analyse liquids. As human cells and indeed the entire human body is ~70% water, this means that the IBC will be able to analyse cells and see, for instance, the interaction between chemotherapeutic drugs and radiation.

Research on non liquid samples using the IBC’s horizontal beam lines has already answered questions such as: what is the composition of paints in 16th century paintings? What is in the particulate matter that comes out of volcanoes? What are the metal atoms in proteins and how many are there? How do parasitic wasps lay their eggs? And what makes 1920’s German bank notes toxic?

The new vertical nanobeam will also have many other applications including chemistry at the atomic scale, the creation of novel materials and nanostructures and other, as yet unknown procedures.

Stuart Miller | alfa
Further information:
http://www.surrey.ac.uk

More articles from Medical Engineering:

nachricht Medical gamma-ray camera is now palm-sized
23.05.2017 | Waseda University

nachricht Computer accurately identifies and delineates breast cancers on digital tissue slides
11.05.2017 | Case Western Reserve University

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>